International journal of medical sciences · 2026
Effects of Ranolazine on Vascular Adrenergic Receptors in Rabbit Aorta.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Jorda Adrian, Mauricio Maria Dolores, Guerra-Ojeda Solanye, Vila Jose M, Valles Soraya L, Aldasoro Martin
Аннотация
BACKGROUND: Different mechanisms of action have been proposed for Ranolazine (Rn), mainly the inhibition of the late sodium current and antagonism of α₁-adrenergic receptors. In the present study, we evaluated the possible involvement of other adrenergic receptors, specifically α₂, β₂, and β₃, as mediators of the vascular effects of Rn.
METHODS: Segments of rabbit aorta were mounted in an organ bath. Electrical field stimulation (EFS; 2, 4, and 8 Hz) induced frequency-dependent contractions that were abolished by tetrodotoxin, prazosin, or guanethidine (10⁻⁶ M), confirming the neural origin of the vascular responses. The effects of Rn on vascular responses to adrenergic stimulation were evaluated by incubating the preparations with increasing concentrations of the drug (10⁻⁷-10⁻⁴ M) for 20 minutes prior to neural stimulation (4 Hz). The involvement of α₁-, α₂-, β₂-, or β₃-adrenergic receptors was assessed using specific antagonists (10⁻⁶ M): prazosin (α₁), yohimbine (α₂), butaxamine (β₂), and SR59230A (β₃). Subsequently, the sequence of electrical field stimulations was performed in the presence of Rn. Expression levels of α₁-, α₂-, β₂-, and β₃-adrenergic receptors were determined by Western blot analysis.
RESULTS: Rn decreases the contractile effect induced by adrenergic nerve stimulation in the rabbit aorta. In the presence of prazosin or yohimbine, the vasoconstrictor response was significantly reduced. However, incubation with butaxamine or SR59230A significantly increased the contractile response to adrenergic nerve stimulation. The protein expression of α1 and α2 receptors significantly decreased compared to the control when incubated with Rn. In contrast, the expression of β2 and β3 receptors increased only at 10⁻⁷ M, a concentration lower than that reached with therapeutic doses of Rn.
CONCLUSION: Rn inhibits the vasoconstrictor response to adrenergic nerve stimulation through an antagonistic effect on α1 and α2 receptors and enhancing the vasodilatory responses mediated by β2 and β3 adrenergic receptors.
METHODS: Segments of rabbit aorta were mounted in an organ bath. Electrical field stimulation (EFS; 2, 4, and 8 Hz) induced frequency-dependent contractions that were abolished by tetrodotoxin, prazosin, or guanethidine (10⁻⁶ M), confirming the neural origin of the vascular responses. The effects of Rn on vascular responses to adrenergic stimulation were evaluated by incubating the preparations with increasing concentrations of the drug (10⁻⁷-10⁻⁴ M) for 20 minutes prior to neural stimulation (4 Hz). The involvement of α₁-, α₂-, β₂-, or β₃-adrenergic receptors was assessed using specific antagonists (10⁻⁶ M): prazosin (α₁), yohimbine (α₂), butaxamine (β₂), and SR59230A (β₃). Subsequently, the sequence of electrical field stimulations was performed in the presence of Rn. Expression levels of α₁-, α₂-, β₂-, and β₃-adrenergic receptors were determined by Western blot analysis.
RESULTS: Rn decreases the contractile effect induced by adrenergic nerve stimulation in the rabbit aorta. In the presence of prazosin or yohimbine, the vasoconstrictor response was significantly reduced. However, incubation with butaxamine or SR59230A significantly increased the contractile response to adrenergic nerve stimulation. The protein expression of α1 and α2 receptors significantly decreased compared to the control when incubated with Rn. In contrast, the expression of β2 and β3 receptors increased only at 10⁻⁷ M, a concentration lower than that reached with therapeutic doses of Rn.
CONCLUSION: Rn inhibits the vasoconstrictor response to adrenergic nerve stimulation through an antagonistic effect on α1 and α2 receptors and enhancing the vasodilatory responses mediated by β2 and β3 adrenergic receptors.